TESTAI, LARA
 Distribuzione geografica
Continente #
NA - Nord America 8.962
EU - Europa 4.734
AS - Asia 1.336
AF - Africa 190
SA - Sud America 25
OC - Oceania 14
Continente sconosciuto - Info sul continente non disponibili 3
Totale 15.264
Nazione #
US - Stati Uniti d'America 8.700
IT - Italia 1.966
SE - Svezia 754
CN - Cina 719
DE - Germania 497
BG - Bulgaria 441
CA - Canada 258
AT - Austria 250
VN - Vietnam 207
GB - Regno Unito 194
TR - Turchia 165
UA - Ucraina 130
FI - Finlandia 127
CI - Costa d'Avorio 125
FR - Francia 91
SG - Singapore 91
BE - Belgio 76
PL - Polonia 53
HK - Hong Kong 52
RU - Federazione Russa 52
IN - India 48
SN - Senegal 45
CH - Svizzera 41
NL - Olanda 17
NG - Nigeria 15
BR - Brasile 14
AU - Australia 13
IR - Iran 11
KR - Corea 8
PK - Pakistan 8
CL - Cile 7
HU - Ungheria 6
ES - Italia 5
GR - Grecia 5
JP - Giappone 5
HR - Croazia 4
LU - Lussemburgo 4
MX - Messico 4
SK - Slovacchia (Repubblica Slovacca) 4
UZ - Uzbekistan 4
IE - Irlanda 3
IL - Israele 3
KZ - Kazakistan 3
AR - Argentina 2
CZ - Repubblica Ceca 2
DK - Danimarca 2
EE - Estonia 2
EU - Europa 2
MA - Marocco 2
NO - Norvegia 2
RS - Serbia 2
SA - Arabia Saudita 2
TW - Taiwan 2
ZA - Sudafrica 2
A1 - Anonimo 1
AM - Armenia 1
AZ - Azerbaigian 1
BD - Bangladesh 1
BY - Bielorussia 1
CY - Cipro 1
ID - Indonesia 1
IQ - Iraq 1
IS - Islanda 1
LK - Sri Lanka 1
MD - Moldavia 1
MY - Malesia 1
NZ - Nuova Zelanda 1
RO - Romania 1
TN - Tunisia 1
UY - Uruguay 1
VE - Venezuela 1
Totale 15.264
Città #
Woodbridge 1.289
Fairfield 967
Ann Arbor 882
Houston 837
Chandler 788
Ashburn 579
Serra 494
Sofia 441
Milan 424
Seattle 377
Wilmington 352
Cambridge 318
Beijing 303
New York 244
Ottawa 241
Vienna 204
Princeton 187
Jacksonville 172
Lawrence 172
Izmir 146
Medford 134
Nanjing 126
Abidjan 125
Des Moines 108
Frankfurt am Main 87
Dong Ket 81
Brussels 73
London 68
Florence 61
Pisa 61
Dearborn 60
Rome 52
San Diego 50
Nanchang 48
Warsaw 48
Dakar 45
Hong Kong 44
Redwood City 41
Boulder 40
Grafing 39
Marseille 38
Bern 32
Washington 31
Hebei 25
Jüchen 25
Shenyang 25
Kunming 24
Norwalk 23
Pune 22
Jiaxing 20
Boardman 19
Bremen 18
Changsha 18
Hangzhou 18
Nürnberg 18
Falls Church 17
Lancaster 17
Tianjin 17
Guangzhou 16
Auburn Hills 15
Lagos 15
Livorno 15
Hefei 13
Jinan 9
Los Angeles 9
Shanghai 9
Toronto 8
Amsterdam 7
Incisa 7
Indiana 7
Istanbul 7
Napoli 7
Pontedera 7
Scafati 7
Vicopisano 7
Bologna 6
Capannori 6
Detroit 6
Islamabad 6
Kocaeli 6
Orange 6
Palermo 6
Pieve 6
Redmond 6
San Francisco 6
Singapore 6
Chicago 5
Dallas 5
Edinburgh 5
Genoa 5
Haikou 5
Helsinki 5
Lucca 5
Massa Marittima 5
Melbourne 5
Montalto Di Castro 5
Pistoia 5
San Mateo 5
Siena 5
Viareggio 5
Totale 11.516
Nome #
Rimedi fitoterapici per la sindrome dell’ovaio policistico. Review di clinical trials 236
Different patterns of H2S/NO activity and cross-talk in the control of the coronary vascular bed under normotensive or hypertensive conditions 219
Iminothioethers as Hydrogen Sulfide Donors: From the Gasotransmitter Release to the Vascular Effects 180
A NEW NITRIC OXIDE RELEASING ANTI-DIABETIC HYBRID DRUG: FROM THE DESIGN TO THE PHARMACOLOGICAL CHARACTERIZATION 175
Hydrogen sulfide releasing capacity of natural isothiocyanates: is it a reliable explanation for the multiple biological effects of brassicaceae? 173
The Citrus Flavanone Naringenin Protects Myocardial Cells against Age-Associated Damage 172
The novel H2S-donor 4-carboxyphenyl isothiocyanate promotes cardioprotective effects against ischemia/reperfusion injury through activation of mitoKATP channels and reduction of oxidative stress 168
Nuovi attivatori dell’enzima SIRT1 per il trattamento delle patologie cardiovascolari e cardiometaboliche 168
Antioxidant and Antisenescence Effects of Bergamot Juice 164
The citrus flavanone naringenin produces cardioprotective effects in hearts from 1 year old rat, through activation of mitoBK channels 162
New NO-Releasing Pharmacodynamic Hybrids of Losartan and Its Active Metabolite: Design,Synthesis, and Biopharmacological Properties 157
The activation of mitochondrial BK potassium channels contributes to the protective effects of naringenin against myocardial ischemia/reperfusion injury 157
R(+)-METHANANDAMIDE INHIBITS EFS-INDUCED CHOLINERGIC RESPONSE IN GUINEA-PIG TRACHEA THROUGH A VR-MEDIATED MECHANISM 155
AN IN VIVO EXPERIMENTAL METHOD TO PREDICT THE TORSADOGENIC POTENTIALITY OF DRUGS: EVALUATION OF QT PROLONGATION IN ANAESTHETISED GUINEA-PIG 154
The Citrus Flavonoid Naringenin Protects the Myocardium from Ageing-Dependent Dysfunction: Potential Role of SIRT1 151
ROLE OF ENDOTHELIAL NO IN THE VASORELAXING EFFECTS INDUCED BY H2S IN CONDUCTANCE AND RESISTANCE RAT ARTERIES 149
Arylthioamides as H2S Donors:l-Cysteine-Activated Releasing Properties and Vascular Effects in Vitro and in Vivo 149
ANTI-ISCHEMIC PROPERTIES OF A NEW SPIRO-CYCLIC BENZOPYRAN ACTIVATOR OF CARDIAC MITOCHONDRIAL ATP-SENSITIVE POTASSIUM CHANNELS 148
R+-METHANANDAMIDE INHIBITS TRACHEAL RESPONSE TO ENDOGENOUSLY RELEASED ACETYLCHOLINE VIA CAPSAZEPINE-SENSITIVE RECEPTORS 148
Protective effect of high-dose montelukast on salbutamol-induced homologous desensitisation in airway smooth muscle. 147
Valore nutraceutico dei flavonoidi presenti nel genere Citrus. Evidenze epidemiologiche, cliniche e pre-cliniche degli effetti protettivi dei Citrus flavanoni sulle funzioni cardiovascolari 138
Hydrogen Sulphide: Biopharmacological Roles in the Cardiovascular System and Pharmaceutical Perspectives. 138
1,4-Benzothiazine ATP-Sensitive Potassium Channel Openers: Modifications at the C-2 and C-6 Positions 137
Flavonoids and mitochondrial pharmacology: A new paradigm for cardioprotection 137
NSAID-induced enteropathy: are the currently available selective COX-2 inhibitors all the same? 131
Mitochondrial Potassium Channels as Pharmacological Target for Cardioprotective Drugs 131
Synthesis and evaluation of multi-functional NO-donor/insulin-secretagogue derivatives for the treatment of type II diabetes and its cardiovascular complications 129
Pharmacological study on the cardiovascular activity of no-sartans, pharmacodynamic hybridsexhibiting at1-antagonist and no-donor properties 127
Anti-ischemic properties of a new spiro-cyclic benzopyran activator of the cardiac mito-KATP channel 127
Anticancer properties of erucin, an H2S-releasing isothiocyanate, on human pancreatic adenocarcinoma cells (AsPC-1) 127
Pharmacological characterization of the vascular effects of aryl isothiocyanates: Is hydrogen sulfide the real player? 125
NOVEL ANALGESIC/ANTI-INFLAMMATORY AGENTS: 1,5-DIARYLPYRROLE NITROOXYALKYL ETHERS AND RELATED COMPOUNDS AS CYCLOOXYGENASE-2 INHIBITING NITRIC OXIDE DONORS 124
SYNTHESIS AND BETA-BLOCKING ACTIVITY OF (R,S)-(E)-OXIMEETHERS OF 2,3-DIHYDRO-1,8-NAPHTHYRIDINE AND 2,3-DIHYDROTHIOPYRANO[2,3-B]PYRIDINE: IDENTIFICATION OF BETA 3-ANTAGONISTS 123
The nutraceutical value of olive oil and its bioactive constituents on the cardiovascular system. Focusing on main strategies to slow down its quality decay during production and storage 123
VASORELAXATION BY HYDROGEN SULPHIDE INVOLVES ACTIVATION OF KV7 POTASSIUM CHANNELS 122
QT PROLONGATION IN GUINEA PIGS FOR PRELIMINARY SCREENING OF TORSADOGENICITY OF DRUGS AND DRUG-CANDIDATES. II 120
Spirocyclic Benzopyran-based derivatives as new anti-ischemic activators of mitochondrial ATP-sensitive potassium channel 120
New Benzopyran-Based Openers of the Mitochondrial ATP-Sensitive Potassium Channel with Potent Anti-Ischemic Properties 119
(+/-)-NARINGENIN AS LARGE CONDUCTANCE Ca2+-ACTIVATED K+ (BKCa) CHANNEL OPENER IN VASCULAR SMOOTH MUSCLE CELLS 119
Voltage-operated potassium (Kv) channels contribute to endothelium-dependent vasorelaxation of carvacrol on rat aorta 119
Impact of mucoadhesive polymeric nanoparticulate systems on oral bioavailability of a macromolecular model drug 118
VASORELAXING EFFECTS OF H2S IN RAT MESENTERIC ARTERIES 116
ACTIVATION OF VASCULAR KV7 POTASSIUM CHANNELS CONTRIBUTES TO THE VASODILATOR EFFECTS OF HYDROGEN SULPHIDE 115
Enhancing the pharmacodynamic profile of a class of selective COX-2 inhibiting nitric oxide donors. 115
VASODILATOR ACTIVITY OF MICHELIA FIGO SPRENG (MAGNOLIACEAE) BY IN VITRO FUNCTIONAL STUDY 114
Cardiac ATP-sensitive potassium channels, a potential target for an anti-ischaemic pharmacological strategy 114
A New Calcium Oral Controlled-Release System Based on Zeolite for Prevention of Osteoporosis 114
Vasorelaxing effects of flavonoids: investigation on the possible involvement of potassium channels 114
Vasodilator activity of crude methanolic extract of Gentiana Kokiana Perr Et Song (Gentianaceae) 111
Novel 1,4-benzothiazine derivatives as large conductance Ca(2+)-activated potassium channel openers 110
New spiromorpholone- and spiromorpholine-benzopyrane derivatives as potential activators of mito-KATP channel 109
H2S-RELEASING PROPERTIES OF NEW THIOAMIDE, IMINOTHIOETHER AND ISOTHIOCYANATE DERIVATIVES 109
Evaluation of the NO-releasing properties of NO-donor linkers 109
QUANTITATIVE STRUCTURE-ACTIVITY RELATIONSHIP MODELS FOR PREDICTING BIOLOGICAL PROPERTIES, DEVELOPED BY COMBINING STRUCTURE- AND LIGAND-BASED APPROACHES: AN APPLICATION TO THE HUMAN ETHER-A-GO-GO-RELATED GENE POTASSIUM CHANNEL INHIBITION 109
VASORELAXATION BY HYDROGEN SULPHIDE INVOLVES ACTIVATION OF KV7 POTASSIUM CHANNELS 108
TORSADOGENIC CARDIOTOXICITY OF ANTIPSYCHOTIC DRUGS: A STRUCTURAL FEATURE, POTENTIALLY INVOLVED IN THE INTERACTION WITH CARDIAC HERG POTASSIUM CHANNELS 106
ANTI-ISCHEMIC ACTIVITY OF AN ANTIOXIDANT ALDOSE REDUCTASE INHIBITOR ON DIABETIC AND NON-DIABETIC RAT HEARTS 105
Synthesis of heterocycle-based analogs of resveratrol and their antitumor and vasorelaxing properties 104
null 104
Mitochondriotropic and Cardioprotective Effects of Triphenylphosphonium-Conjugated Derivatives of the Diterpenoid Isosteviol 104
By-products from winemaking and olive mill value chains for the enrichment of refined olive oil: Technological challenges and nutraceutical features 103
Functional contribution of the endothelial component to the vasorelaxing effect of resveratrol and NS 1619, activators of the large-conductance calcium-activated potassium channels 102
NO-glibenclamide derivatives: prototypes of a new class of nitric oxide-releasing anti-diabetic drugs 102
VASORELAXANT EFFECTS OF THE CHLOROFORMIC CRUDE EXTRACT OF BUPLEURUM FRUTICOSUM L. (UMBELLIFERAE) ROOTS ON RAT THORACIC AORTA 101
Anti-ischemic properties of new spiro-morpholine benzopyrane derivatives, potential activators of mitochondrial atp-sensitive potassium channel, on isolated rat hearts 99
THIOAMIDE, IMINOTHIOETHER AND ISOTHIOCYANATE DERIVATIVES: CHEMOTYPES OF SLOW H2S-RELEASING AGENTS 99
QT PROLONGATION IN ANAESTHETIZED GUINEA-PIGS: AN EXPERIMENTAL APPROACH FOR PRELIMINARY SCREENING OF TORSADOGENICITY OF DRUGS AND DRUG CANDIDATES 99
Synthesis and evaluation of antihypertensive activity of 1,8-naphthyridine derivatives. Part X 99
Matrix metalloproteinase-12 inhibitors: synthesis, structure-activity relationships and intestinal absorption of novel sugar-based biphenylsulfonamide carboxylates 98
APRIKALIM ABOLISHES THE QT INTERVAL PROLONGATION THIORIDAZINE-INDUCED BY THE ACTIVATION OF SARCOPLASMIC KATP CHANNELS 97
Effect of glucoraphanin and sulforaphane against chemotherapy-induced neuropathic pain: Kv7 potassium channels modulation by H2S release in vivo 95
IMPROVING THE SOLUBILITY OF A NEW CLASS OF ANTIINFLAMMATORY PHARMACODYNAMIC HYBRIDS, THAT RELEASE NITRIC OXIDE AND INHIBIT CYCLOXYGENASE-2 ISOENZYME 94
QSAR models for predicting biological properties, developed by combining structure- and ligand-based approaches: an application to the hERG potassium channel inhibition 93
null 92
null 91
HYDROGEN SULPHIDE: NOVEL OPPORTUNITY FOR DRUG DISCOVERY 91
null 91
EFFECTS OF TSPO-LIGANDS ON MITOCHONDRIAL VOLUME AND MITOCHONDRIAL MEMBRANE POTENTIAL 90
HIGHLY POTENT 1,4-BENZOTHIAZINE DERIVATIVES AS K(ATP)-CHANNEL OPENERS 90
The Renal Outer Medullary Potassium channel (ROMK): an intriguing pharmacological target for an innovative class of diuretic drugs 90
Erucin exhibits vasorelaxing effects and antihypertensive activity by H 2 S-releasing properties 90
Structure-activity relationships study of isothiocyanates for H2S releasing properties: 3-Pyridyl-isothiocyanate as a new promising cardioprotective agent 90
The novel anti-inflammatory agent VA694, endowed with both NO-releasing and COX2-selective inhibiting properties, exhibits NO-mediated positive effects on blood pressure, coronary flow and endothelium in an experimental model of hypertension and endothelial dysfunction 89
null 89
New activators of SIRT1 enzyme for the treatment of cardiovascular and cardiometabolic pathologies 88
HIGHLY POTENT KATP CHANNEL ACTIVATORS 87
SYNTHESIS AND BIOLOGICAL EVALUATION OF 5-MEMBERED SPIRO HETEROCYCLE-BENZIPYRAN DERIVATIVES AGAINST MYOCARDIAL ISCHEMIA 87
ROLE OF BK POTASSIUM CHANNELS IN THE VASORELAXING EFFECTS OF FLAVONOIDS 86
(+/-)-NARINGENIN AS KCA 1.1 CHANNEL OPENER IN VASCULAR SMOOTH MUSCLE CELLS 86
Enantioselectivity in Cardioprotection induced by (S)- (-)-2,2-Dimethyl-N-(4'-acetamido-benzyl)-4-spiromorpholone-chromane 86
NOVEL ANALGESIC/ANTI-INFLAMMATORY AGENTS: DIARYLPYRROLE ACETIC ACID ESTERS ENDOWED WITH NITRIC OXIDE RELEASING PROPERTIES 86
Ex vivo and in vivo study of sucrosomial® iron intestinal absorption and bioavailability 85
ATTIVATORI DEI CANALI KATP A STRUTTURA 1,4-BENZOTIAZINICA: MODIFICAZIONI IN C-2 E C-6 82
Development of fortified citrus olive oils: From their production to their nutraceutical properties on the cardiovascular system 82
THE XANTHONES GENTIACAULEIN AND GENTIAKOCHIANIN ARE RESPONSIBLE FOR THE VASODILATOR ACTION OF THE ROOTS OF GENTIANA KOCHIANA 81
A Nutraceutical Strategy to Slowing Down the Progression of Cone Death in an Animal Model of Retinitis Pigmentosa 81
NATURAL AND SYNTHETIC POTASSIUM CHANNEL ACTIVATORS 79
Cardioprotective effects of different flavonoids against myocardial ischemia/reperfusion injury in Langendorff-perfused rat hearts. 79
Efficacy of isothiocyanate-based compounds on different forms of persistent pain 79
null 78
Totale 11.682
Categoria #
all - tutte 34.770
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 34.770


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019983 0 0 0 0 0 0 0 40 44 310 335 254
2019/20202.839 346 201 257 193 250 287 330 223 269 194 213 76
2020/20211.619 126 93 82 73 131 129 116 150 218 145 90 266
2021/20221.958 38 163 61 77 340 302 56 108 75 55 146 537
2022/20232.871 315 367 183 226 312 371 55 195 565 24 159 99
2023/20241.638 234 258 233 130 266 399 71 47 0 0 0 0
Totale 15.723